Community Spirit Acupuncture London

Wimbledon Acupuncture Clinic



Community Spirit is an affordable acupuncture clinic in South Wimbledon, London. We are a short walk from Colliers Wood tube station on the Northern Line.

Clinics run:
Every Tuesday from 2.00pm to 6.30pm

All Saints Centre
44 All Saints Road
SW19 1BX

07791 414 440 Sue

Map & Directions

Because of our location close to the Northern Line stations of Colliers Wood and South Wimbledon, we are easy to get to from Tooting Bec, Tooting Broadway, Mitcham and Morden, as well as Wimbledon itself. Follow the link above for location, directions and travel information.

British Acupuncture Council logo 

ACMAC logo

[migraine and acupuncture]

An Overview of Drugs For Acute Treatment of Migraine Headaches

The table below outlines the uses and side effects of the most common acute migraine treatment drugs

(Back to main article: Migraines, Drugs, Acupuncture and other Therapies)

Please note: The information below has been compiled from the British National Formulary 57 and the Journal of Neurological Sciences. Consult a qualified physician before making changes or additions to your drug regimen.

Drug Group

Drug Name (& Recommended Use)

Side Effects


Simple Analgesics

Asprin (650mg dose at onset).

GI problems, bleeding.

Most effective when taken early and when pain intensity is mild & not associated with nausea. Efficacy increased with addition of metoclopramide (5-10mg).

Acetaminophen (1000mg with repeat in 2hr).

Anxiety, dyskinesia.

Not ideal first line choice - beneficial to patients with contraindications to other therapies (eg pregnancy, bruisability, asprin hypersensitivity).

Nonsteroidal Anti-Inflamatory Agents (NSAIDs)

Diclofenac-K (50-100mg).

Flurbiprofen (100-300mg).

Ibprofen (200-800mg).

Naproxen sodium (550-1100mg).

Piroxicam SL (40mg).

Tolfenamic acid (200-400mg).


Proven clinically effective. Lack of response to one does not indicate response to another will be also negative. Very effective in office or ER situation.

Opiate Analgesics

Codeine, morphine, levorphanol, hydormorphone, hydrocodone, oxycodone, etc.

Drowsiness, decreased cognitive sharpness.

Useful in emergency room setting if vasoactive drugs fail or are contraindicated.

Ergot Alkaloids

Ergotamine tartrate (maximum dose 4mg/day, 1/2 days/week).

Nausea, vomiting, abdominal pain, distal paraesthesia, muscle cramps. Exceeding recommended dose can induce rebound headache and dependency.

Migraine specific medication. Orally poorly absorbed (<5% bioavailable). Rectal administration slightly better absorption/efficacy. Contraindicated in pregnancy, hypertension, coronary artery disease, peripheral vascular disease, sepsis, liver and kidney disease. Used when triptans have failed.

Dihydroergotamine (nasally: 0.5mg/nostril, repeated 15min later, total of 4 applications, IV: 0.25-0.5mg).


Clinically proven when administered IV, IM, sub-cutaneously or intranasally. Appears to work well into migraine attack. Contraindications as per ergotamine tartrate.


Sumatriptan, zolmitriptan, naratriptan, rizatriptan, almotriptan, fovatriptan, eletriptan.

Hepatic impairment, renal impairment, increase in blood pressure, drowsiness, abdominal pain, dry mouth, dyspepsia, tachycardia, palpitation, headache, pharyngitis, rhinitis, chills, myasthenia, myalgia, sweating, paraesthesia, visual disturbances, myalgia, muscle weakness.

Currently most migraine specific and selective treatment. Differences in pharmacokinetic profiles across different triptans exist, but it is not clear how these differences translated in to clinical efficacy/tolerability. Method of delivery may be more important than choice of triptan. Subcutaneous delivery most rapid/complete, but also associated with higher risk of side effects/recurrence. Cannot predict which triptan will work best with which patient. Very safe if no contraindications. Contraindications: patients with vascular risk (coronary heart disease, diabetes, peripheral vascular or cerebrovascular disease, hypertension, Raynaud's).


  1. British National Formulary 56. (2008). London: BMJ Group & RPS Publishing.
  2. Rapoport, A.M. (2008). Acute and prophylactic treatments for migraine: present and future. Neurological Sciences, 29 (S1), S110-S122. .